EvogeneEVGN
13F holders, Q2 2026 (June 30)13holders −2
3new positions
5sold out
1famous investor
$0.43avg. 13F price*
At the end of Q2 2026, 13 institutions reported holding Evogene Ltd. (EVGN) in their 13F filings, down 2 from Q1 2026. 3 opened new positions and 5 sold out. The largest holders were HRT Financial LP ($45K), Susquehanna International Group, LLP ($34K) and Citadel Advisors ($21K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Evogene Ltd.
- CUSIP
- M4119S187
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $100K |
| Exits | 5 | $376K |
All 13F filers, Q1 2026 → Q2 2026: 248,923 shares bought and 497,391 shares sold, net −248,468 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 13 holders
| HRT Financial LP | 0.00% | New | 107,198 | $45K |
| Susquehanna International Group, LLP | 0.00% | New | 80,078 | $34K |
| Citadel Advisors | 0.00% | New | 50,526 | $21K |
| XTX Topco Ltd | 0.00% | Add +52.5% | 19,404 | $8K |
| UBS Group AG | 0.00% | Add +69.9% | 10,790 | $5K |
| Daytona Street Capital LLC | 0.00% | Reduce -3.5% | 9,253 | $5K |
| BNP Paribas Financial Markets | 0.00% | Reduce -69.0% | 2,830 | $1K |
| Morgan Stanley | 0.00% | Reduce -66.6% | 1,285 | $564 |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 500 | $220 |
| Osaic Holdings, Inc. | 0.00% | No change | 100 | $44 |
| SHP Wealth Management | 0.00% | No change | 65 | $29 |
| SBI Securities Co., Ltd. | 0.00% | Reduce -13.9% | 62 | $27 |
| Royal Bank of Canada | 0.00% | No change | 42 | $0 |
"% of holder's portfolio" is EVGN's weight in each manager's 13F, not the share of Evogene Ltd. the manager owns.